Featured Products & Services

  1. A Single-Use Chromatography System For Scale-Up And GMP Manufacturing 5/13/2024

    ÄKTA ready™ is a single-use liquid chromatography system built for process scale-up and GMP manufacturing. The single-use flow path minimizes the need for cleaning and cleaning validation, allowing for quick changeover between productions and reducing the risk of carryover. The ÄKTA ready chromatography system offers the performance and documentation required for use in a GMP-regulated environment.

  2. Chromatography Single-Use Systems 5/7/2024

    ÄKTA™ single-use chromatography systems are designed where speed and flexibility are needed. Single-use flow kits eliminate the need for system cleaning and validation, reduce downtime and minimize risk for cross-contamination between product/batches. All systems are controlled by UNICORN™ software, a common control platform and user interface for all scales of operation.

  3. Bionanoparticle Technology 4/24/2023

    Nanoform’s proprietary bionanoparticle technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. This can not only enable more patient-friendly approaches to drug delivery, but also potentially higher loads of active ingredients.

  4. jetMESSENGER®: mRNA Transfection Reagent 3/21/2023

    Take your gene expression to the next level by switching to mRNA!

    Primary cells, neurons, suspension cells and various cancer cell lines are especially challenging to transfect. jetMESSENGER® gives high transfection efficiency in all of these usually difficult to transfect cells, by allowing highly efficient mRNA transfection.

    mRNA transfection is as easy as DNA transfection, with the advantage that mRNA does not need to reach the cell nucleus for expression nor require cell division for efficient gene expression. Hence, cells that are slow dividing or that have developed specific mechanisms to protect their genome can finally be used for gene expression.

    Unravel the full potential of your cells by switching to mRNA transfection.

  5. Non-Viral In Vivo Transfection - Cationic Lipids For LNP Formulation 7/13/2023

    LipidBrick® IM21.7c

    •  Efficient: Modulates LNP properties to adapt the biodistribution depending on the therapeutic purpose
    •  Secure: Use a unique lipid structure protected by an independent patent owned by Polyplus®
    •  Accelerate your project: in vitro and in vivo proof of concept have been successfully performed
  6. Site Management Organization 11/7/2023

    Discover the power of clinical excellence with Acrostar's SMO Division, a dedicated entity operating as part of Novotech.

  7. Pharmacometric Services 6/27/2023

    Our talented and experienced team can assist in all Clinical Study Phases (Phase 0, I, II and III) and in study designs ranging from First in Human (FIH), Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), Drug-Drug Interaction (DDI), Bioavailability/Bioequivalence (BA/BE), Food Effect as well as Special Population studies.

  8. Fast Purification - ÄKTA pure Chromatography System 6/5/2024

    ÄKTA pure™ is a flexible and intuitive chromatography system for fast purification of proteins, peptides, and nucleic acids from microgram levels to tens of grams of target product in research scale applications. ÄKTA pure™ is a reliable system where hardware and UNICORN™ system control software are designed to work together with columns and media to meet any purification challenge.

  9. Comprehensive mRNA Solutions 1/31/2025

    Curia’s combined expertise and a proven track record of success in key scientific disciplines including molecular biology, protein production and analysis, enzymes, nucleosides and lipids is the foundation of our mRNA solution. Partner with us and harness our ability to provide high-quality constructs through in-house research and analysis capabilities that enable accelerated timelines for delivery.

  10. Oncology CRO Services 6/27/2023

    Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes, and relatively high costs.